| Lot Release Number |
2019-11-13-0278
|
| FDA Registered Product/Generic Name |
Diphtheria, Tetanus and Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type B Conjugate Vaccine, Adsorbed
|
| Brand Name |
Infanrix-IPV+Hib
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension for Injection (Deep I.M.), 2PE Free
|
| Registration Number |
BR-659
|
| Batch/Lot Number |
A20CB557 (DTPa-IPV: AC20B395A; HiB: AHIBD392B)
|
| Packaging Lot |
Packaging lot (box): A20CB557C
Pre-filled syringe: A20LB557C, ED 08-2021
Vial: A20FB557C, MD 07-2019, ED 06-2022;
Needles (25G x 1"): 1907007, ED 2024-06-30
|
| Product Expiration Date |
31 August 2021
|
| Issuance Date |
15 November 2019
|